BCN3D has voluntarily filed for chapter in line with studies in Spain.
Barcelona-based digital media outlet Crónica World reported final week that BCN3D had did not efficiently negotiate a restructuring of its money owed with collectors.
A chapter administrator has been appointed with the corporate’s future unclear.
BCN3D launched in 2018, bringing to market a portfolio of extrusion desktop 3D printers to market, whereas additionally growing the Viscous Lithography Manufacturing (VLM) know-how it will later carve out by way of the Supernova enterprise. Amongst BCN3D’s flagship merchandise had been the Omega I60 3D printing system and its Epsilon Collection, which got here with the promise of manufacturing ‘exceptionally robust’ components at excessive speeds.
Regardless of the corporate’s finest efforts, it has been unable to distinguish itself within the aggressive desktop 3D printing panorama. Crónica World studies that its revenues dropped by 25% in 2023 in comparison with the earlier yr, with the corporate recording a web lack of over one million Euros. Over time, the corporate raised round 10 million EUR by way of personal funding, with an extra 7 million EUR coming in public subsidies. Final yr, the corporate secured what it described as ‘pivotal funding’ as it launched a brand new 3D printer manufacturing facility.
Although the funding was thought-about important, it has not been sufficient to stave off chapter. Crónica World studies that on the time of submitting, BCN3D had property valued at round 10 million EUR, with liabilities of seven million EUR. The corporate has but to publicly affirm it has filed for chapter, however has used its social channels in latest days to re-post a Forbes article from 2020 rounding up the funding raised by 3D printing corporations through the Covid-19 pandemic and spotlight a buyer success story.
In mild of BCN3D’s chapter submitting, Supernova has sought to make clear that it’s “a totally impartial firm with no authorized ties to BCN3D and is due to this fact by no means affected by this example.” The corporate has additionally claimed that studies of a key companion withdrawing its help are ‘fully unfounded.’